Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
This study has been completed.
Study NCT00545051   Information provided by Hoffmann-La Roche

First Received on October 16, 2007.   Last Updated on December 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post-Menopausal Osteoporosis
Additional conditions recognized in this trial
Osteoporosis
Osteoporosis, Postmenopausal
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Musculoskeletal Diseases
Interventions listed in this trial
ibandronate [Bonviva/Boniva]
Placebo
Additional drug interventions recognized in this trial
Glucocorticoids
Ibandronic acid
More general drug interventions related to this trial
Bone Density Conservation Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Hoffmann-La Roche
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services